These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 25654571)
1. [Risk management with regard to QT-prolonging drugs]. Aengevaeren VL; van Gastel MDA; Fleuren HWHA; Helsloot I; Beukema RJ; Kramers C Ned Tijdschr Geneeskd; 2024 Jun; 168():. PubMed ID: 38888230 [TBL] [Abstract][Full Text] [Related]
2. Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End-Stage Kidney Disease. Assimon MM; Wang L; Pun PH; Winkelmayer WC; Flythe JE J Am Heart Assoc; 2020 Jul; 9(13):e015969. PubMed ID: 32578475 [TBL] [Abstract][Full Text] [Related]
3. Management of serious cardiac adverse effects of antipsychotic medications. Stoner SC Ment Health Clin; 2017 Nov; 7(6):246-254. PubMed ID: 29955530 [TBL] [Abstract][Full Text] [Related]
4. Molecular Study of Sudden Cardiac Death. Hostiuc S Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928072 [TBL] [Abstract][Full Text] [Related]
5. Philemon and Baucis death: a literature review. Sottmann L; Schmeling A Int J Legal Med; 2024 May; 138(3):1011-1021. PubMed ID: 37981585 [TBL] [Abstract][Full Text] [Related]
6. Antipsychotic medications and cardiac conduction risks. Roman M; Farmer SY Issues Ment Health Nurs; 2010 Jan; 31(1):68-70. PubMed ID: 19951166 [No Abstract] [Full Text] [Related]
7. Drug-induced q-T prolongation. Kao LW; Furbee RB Med Clin North Am; 2005 Nov; 89(6):1125-44, x. PubMed ID: 16227057 [TBL] [Abstract][Full Text] [Related]